INS and gestational diabetes: Such an association may be a desirable approach for women with GDM with glucose levels that remain above the range despite the maximum tolerated by oral monotherapy.(8) This treatment has the potential to avoid discomfort of subcutaneous injections and the high costs of insulin therapy, as well as possible drawbacks, such as doubts about the correct form of use, forgetting the schedule, and even difficulty in accepting the use of insulin, considering it an aggression to the body.(9,10)